Nutranomics Inc(NNRX)
USD --+0.00%
Reward44Moderate
Risk43Moderate
📊50%Data
Revenue down 36% YoY
NNRX
+0.0 · +0.00%
USD · PINK
Nutranomics Inc | Healthcare
Earnings Deterioration
Market Cap:816232
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
50% data coverage
ℹ️
Risk Rating
43
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NNRX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Nutranomics Inc?

engages in the research, development, and sale of nutritional food products.

NNRX · Verdict

Moderate reward · moderate risk

NNRX stands out on balance sheet and volatility, but watch the cash flow signal.

Based on 75% data coverage

NNRX · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet100/100

    Top decile vs peers

  • Volatility75/100

    Above average

Watchouts 2

  • Cash flow5/100

    Weak vs peers

  • Profitability10/100

    0% return on equity

Model-based scoring. For information only — not financial advice.

What is Nutranomics Inc?

engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 816.23K.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap816.23K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0001
52 Week LowN/A
Last AnnualJuly
IPO DateN/A
IncorporatedUSA
Shares Outstanding16B
No. of Employees1
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta-0.022
CurrencyUSD